Compare HNVR & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HNVR | ORMP |
|---|---|---|
| Founded | 2008 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.5M | 141.3M |
| IPO Year | 2022 | 2010 |
| Metric | HNVR | ORMP |
|---|---|---|
| Price | $23.23 | $4.65 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $24.50 | N/A |
| AVG Volume (30 Days) | 9.3K | ★ 137.0K |
| Earning Date | 04-27-2026 | 05-14-2026 |
| Dividend Yield | 1.72% | ★ 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | 0.25 | ★ 1.50 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | $35.49 | N/A |
| Revenue Next Year | $8.61 | N/A |
| P/E Ratio | $23.31 | ★ $2.70 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $19.91 | $1.98 |
| 52 Week High | $24.49 | $4.22 |
| Indicator | HNVR | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 55.80 | 76.89 |
| Support Level | $22.93 | $3.21 |
| Resistance Level | $24.38 | N/A |
| Average True Range (ATR) | 0.42 | 0.20 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 41.86 | 69.36 |
Hanover Bancorp Inc is a community commercial bank focused on providing personalized and efficient services and products tailored to local needs. The Bank offers a full range of financial services, including a complete suite of consumer, commercial, and municipal banking products such as multifamily and commercial mortgages, government-guaranteed loans, residential loans, business loans, and lines of credit. In addition, it provides customers with access to 24-hour ATM services with no fees, interest-bearing free checking accounts, telephone banking, mobile and internet banking solutions for both consumer and business clients, and safe deposit boxes.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.